FDA Clears Path for Landmark Gene Therapy to Restore Vision in Children
A New Frontier in Pediatric Ophthalmology WASHINGTON, D.C. — In a major development that could reshape the American landscape of pediatric medicine, the Food and Drug Administration (FDA) has formally authorized a groundbreaking gene therapy designed to treat a rare genetic mutation that